litlas
ログインアカウント作成

Lori J. Goldstein

1989–2024 年に発表

75
論文数
23,044
被引用数
67
h 指数
75
i10 指数

被引用数

Lori J. Goldstein の年別被引用数1981 年: 被引用 1 件1989 年: 被引用 9 件1990 年: 被引用 31 件1991 年: 被引用 44 件1992 年: 被引用 41 件1993 年: 被引用 41 件1994 年: 被引用 25 件1995 年: 被引用 32 件1996 年: 被引用 40 件1997 年: 被引用 26 件1998 年: 被引用 24 件1999 年: 被引用 22 件2000 年: 被引用 29 件2001 年: 被引用 35 件2002 年: 被引用 40 件2003 年: 被引用 75 件2004 年: 被引用 70 件2005 年: 被引用 92 件2006 年: 被引用 118 件2007 年: 被引用 103 件2008 年: 被引用 129 件2009 年: 被引用 154 件2010 年: 被引用 160 件2011 年: 被引用 146 件2012 年: 被引用 140 件2013 年: 被引用 116 件2014 年: 被引用 156 件2015 年: 被引用 189 件2016 年: 被引用 162 件2017 年: 被引用 169 件2018 年: 被引用 153 件2019 年: 被引用 533 件2020 年: 被引用 603 件2021 年: 被引用 589 件2022 年: 被引用 518 件2023 年: 被引用 415 件2024 年: 被引用 711 件2025 年: 被引用 249 件2026 年: 被引用 16 件1982〜1988 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,515 件、この内訳の 28.1%中国: 引用元論文 982 件、この内訳の 11%イタリア: 引用元論文 509 件、この内訳の 5.7%イギリス: 引用元論文 424 件、この内訳の 4.8%ドイツ: 引用元論文 397 件、この内訳の 4.4%カナダ: 引用元論文 369 件、この内訳の 4.1%フランス: 引用元論文 295 件、この内訳の 3.3%オーストラリア: 引用元論文 232 件、この内訳の 2.6%スイス: 引用元論文 232 件、この内訳の 2.6%オランダ: 引用元論文 223 件、この内訳の 2.5%日本: 引用元論文 217 件、この内訳の 2.4%スペイン: 引用元論文 210 件、この内訳の 2.4%
0%28.1%その他 26.1%

機関

分野

  • Medicine56.4%
  • Biochemistry, Genetics and Molecular Biology33.4%
  • Immunology and Microbiology2.8%
  • Computer Science2.4%
  • Engineering0.8%
  • Social Sciences0.7%
  • その他3.5%

トピック

  • Breast Cancer Treatment Studies10.5%
  • HER2/EGFR in Cancer Research4.1%
  • Cancer Immunotherapy and Biomarkers3.7%
  • Advanced Breast Cancer Therapies3.4%
  • Breast Lesions and Carcinomas3.2%
  • Cancer Treatment and Pharmacology2.5%
  • その他72.6%

共著者

全論文

検索で開く
  1. Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

    著者: William J. Gradishar, Meena S. Moran, Jame Abraham, Rebecca Aft, Doreen M. Agnese, Kimberly H. Allison, Bethany Anderson, Harold J. Burstein, Helen K. Chew, Chau T. Dang, Anthony Elias, Sharon H. Giordano, Matthew P. Goetz, Lori J. Goldstein, Sara A. Hurvitz, Steven J. Isakoff, Rachel C. Jankowitz, Sara H. Javid, Jairam Krishnamurthy, Marilyn Leitch, Janice A. Lyons, Joanne Mortimer, Sameer A. Patel, Lori J. Pierce, Laura H. Rosenberger, Hope S. Rugo, Amy M. Sitapati, Karen L. Smith, Mary Lou Smith, Hatem Soliman, Erica Stringer-Reasor, Melinda L. Telli, John H. Ward, Kari B. Wisinski, Jessica Young, Jennifer L. Burns, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2022 被引用: 964

  2. 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer

    著者: Kevin Kalinsky, William E. Barlow, Julie R. Gralow, Funda Meric-Bernstam, Kathy S. Albain, Daniel F. Hayes, Nancy U. Lin, Edith A. Perez, Lori J. Goldstein, Stephen K.L. Chia, Sukhbinder Dhesy-Thind, Priya Rastogi, Emilio Alba, Suzette Delaloge, Miguel Martin, Catherine M. Kelly, Manuel Ruiz-Borrego, Miguel Gil-Gil, Claudia H. Arce-Salinas, Etienne G.C. Brain, Eun-Sook Lee, Jean-Yves Pierga, Begoña Bermejo, Manuel Ramos-Vazquez, Kyung-Hae Jung, Jean-Marc Ferrero, Anne F. Schott, Steven Shak, Priyanka Sharma, Danika L. Lew, Jieling Miao, Debasish Tripathy, Lajos Pusztai, Gabriel N. Hortobagyi - New England Journal of Medicine 2021 被引用: 832

  3. NCCN Guidelines® Insights: Breast Cancer, Version 4.2023

    著者: William J. Gradishar, Meena S. Moran, Jame Abraham, Vandana G. Abramson, Rebecca Aft, Doreen M. Agnese, Kimberly H. Allison, Bethany Anderson, Harold J. Burstein, Helen K. Chew, Chau T. Dang, Anthony Elias, Sharon H. Giordano, Matthew P. Goetz, Lori J. Goldstein, Sara A. Hurvitz, Rachel C. Jankowitz, Sara H. Javid, Jairam Krishnamurthy, A. Marilyn Leitch, Janice A. Lyons, Joanne Mortimer, Sameer A. Patel, Lori J. Pierce, Laura H. Rosenberger, Hope S. Rugo, Bryan P. Schneider, Mary Lou Smith, Hatem Soliman, Erica Stringer-Reasor, Melinda L. Telli, Mei Wei, Kari B. Wisinski, Jessica Young, Kay T. Yeung, Mary A. Dwyer, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2023 被引用: 440

  4. Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology

    著者: William J. Gradishar, Benjamin O. Anderson, Jame Abraham, Rebecca Aft, Doreen M. Agnese, Kimberly H. Allison, Sarah L. Blair, Harold J. Burstein, Chau T. Dang, Anthony Elias, Sharon H. Giordano, Matthew P. Goetz, Lori J. Goldstein, Steven J. Isakoff, Jairam Krishnamurthy, Janice A. Lyons, P. Kelly Marcom, Jennifer M. Matro, Ingrid A. Mayer, Meena S. Moran, Joanne Mortimer, Ruth O’Regan, Sameer A. Patel, Lori J. Pierce, Hope S. Rugo, Amy M. Sitapati, Karen L. Smith, Mary Lou Smith, Hatem Soliman, Erica Stringer-Reasor, Melinda L. Telli, John H. Ward, Jessica Young, Jennifer L. Burns, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2020 被引用: 1,618

  5. Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199

    著者: Sylvia Adams, Robert J. Gray, Sandra Demaria, Lori J. Goldstein, Edith A. Perez, Lawrence N. Shulman, Silvana Martino, Molin Wang, Vicky Jones, Thomas J. Saphner, Antonio C. Wolff, William C. Wood, Nancy E. Davidson, George W. Sledge, Joseph A. Sparano, Sunil Badve - Journal of Clinical Oncology 2014 被引用: 1,333

  6. Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2–Negative Metastatic Breast Cancer

    著者: Anne F. Schott, Lori J. Goldstein, Massimo Cristofanilli, Pier Adelchi Ruffini, Susan McCanna, James M. Reuben, Raymond P. Perez, Giraldo Kato, Max S. Wicha - Clinical Cancer Research 2017 被引用: 240

  7. A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer

    著者: Lori J. Goldstein, Raymond P. Perez, Denise A. Yardley, Linda K. Han, James M. Reuben, Hui Gao, Susan McCanna, Beth Butler, Pier Adelchi Ruffini, Yi Liu, Roberto R. Rosato, Jenny C. Chang - Breast Cancer Research 2020 被引用: 137

  8. Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial

    著者: Eve T. Rodler, Priyanka Sharma, William E. Barlow, Julie R. Gralow, Shannon L. Puhalla, Carey K. Anders, Lori J. Goldstein, Debu Tripathy, Ursa Brown‐Glaberman, Thu-Tam Huynh, Christopher S Szyarto, Andrew K. Godwin, Harsh B. Pathak, Elizabeth M. Swisher, Marc R. Radke, Kirsten M. Timms, Danika L. Lew, Jieling Miao, Lajos Pusztai, Daniel F. Hayes, Gabriel N. Hortobágyi - The Lancet Oncology 2023 被引用: 98

  9. Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102

    著者: Noah Kornblum, Fengmin Zhao, Judith Manola, Paula Klein, Bhuvaneswari Ramaswamy, Adam Brufsky, Phillip J. Stella, Brian L. Burnette, Melinda L. Telli, Della Makower, P. Cheema, Cristina I. Truica, Antonio C. Wolff, Gamini S. Soori, Barbara Haley, Timothy R. Wassenaar, Lori J. Goldstein, Kathy D. Miller, Joseph A. Sparano - Journal of Clinical Oncology 2018 被引用: 189

  10. NCCN Guidelines Insights: Breast Cancer, Version 1.2017

    著者: William J. Gradishar, Benjamin O. Anderson, Ronald Balassanian, Sarah L. Blair, Harold J. Burstein, Amy Cyr, Anthony Elias, William B. Farrar, Andres Forero, Sharon H. Giordano, Matthew P. Goetz, Lori J. Goldstein, Steven J. Isakoff, Janice A. Lyons, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Meena S. Moran, Ruth O’Regan, Sameer A. Patel, Lori J. Pierce, Elizabeth Reed, Kilian Salerno, Lee S. Schwartzberg, Amy M. Sitapati, Karen L. Smith, Mary Lou Smith, Hatem Soliman, George Somlo, Melinda L. Telli, John H. Ward, Dorothy A. Shead, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2017 被引用: 542

  11. NCCN Guidelines® Insights: Breast Cancer, Version 4.2021

    著者: William J. Gradishar, Meena S. Moran, Jame Abraham, Rebecca Aft, Doreen M. Agnese, Kimberly H. Allison, Sarah L. Blair, Harold J. Burstein, Chau T. Dang, Anthony Elias, Sharon H. Giordano, Matthew P. Goetz, Lori J. Goldstein, Sara A. Hurvitz, Steven J. Isakoff, Rachel C. Jankowitz, Sara H. Javid, Jairam Krishnamurthy, Marilyn Leitch, Janice A. Lyons, Jennifer M. Matro, Ingrid A. Mayer, Joanne Mortimer, Ruth O’Regan, Sameer A. Patel, Lori J. Pierce, Hope S. Rugo, Amy M. Sitapati, Karen L. Smith, Mary Lou Smith, Hatem Soliman, Erica Stringer-Reasor, Melinda L. Telli, John H. Ward, Kari B. Wisinski, Jessica Young, Jennifer L. Burns, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2021 被引用: 351

  12. A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)

    著者: Lori J. Goldstein, Mauro Mansutti, Christelle Lévy, Jenny C. Chang, Stéphanie Henry, I. Fernández-Pérez, Jana Prausová, Elżbieta Starosławska, Giuseppe Viale, Beth Butler, Susan McCanna, Pier Adelchi Ruffini, Max S. Wicha, Anne F. Schott, for the fRida Trial Investigators, Ricardo H. Álvarez, Anne F. Schott, Maysa Abu‐Khalaf, Nuhad Ibrahim, Brooke Daniel, Michael W. Meshad, David E. Kanamori, Amelia Zelnak, Mark S. Graham, Jason E. Comer, Manon Huizing, François Duhoux, Vincent R. Richard, Didier Verhoeven, Martin Šmakal, Marta Krásenská, Milan Kohoutek, Martina Zimovjanová, Eugen Kubala, Mario Campone, Jean-­Marc Ferrero, Anthony Gonçalvès, Laurence Venat‐Bouvet, Jacques Médioni, Laura Biganzoli, Héctor Soto Parrà, Paolo Pedrazzoli, Marco Colleoni, Mauro Moroni, Dino Amadori, Paolo Morandi, Saverio Cinieri, Piotr Tomczak, Tomasz Sarosiek, Marek Z. Wojtukiewicz, Andrzej Mruk, Bożena Kukiełka-Budny, Silvia Antolin Novoa, Estela Vega Alonso, M. Martín Jiménez - Breast Cancer Research and Treatment 2021 被引用: 101

  13. Goserelin for Ovarian Protection during Breast-Cancer Adjuvant Chemotherapy

    著者: Halle C. F. Moore, Joseph M. Unger, Kelly‐Anne Phillips, Frances Boyle, Erika Hitre, David Porter, Prudence A. Francis, Lori J. Goldstein, Henry Gómez, Carlos Vallejos, Ann H. Partridge, Shaker R. Dakhil, Agustin A. García, Julie R. Gralow, Janine Lombard, John Forbes, Silvana Martino, William E. Barlow, Carol J. Fabian, Lori M. Minasian, Frank L. Meyskens, Richard D. Gelber, Gabriel N. Hortobágyi, Kathy S. Albain - New England Journal of Medicine 2015 被引用: 542

  14. Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology

    著者: William J. Gradishar, Benjamin O. Anderson, Ronald Balassanian, Sarah L. Blair, Harold J. Burstein, Amy Cyr, Anthony Elias, William B. Farrar, Andres Forero, Sharon H. Giordano, Matthew P. Goetz, Lori J. Goldstein, Steven J. Isakoff, Janice A. Lyons, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Meena S. Moran, Ruth O’Regan, Sameer A. Patel, Lori J. Pierce, Elizabeth Reed, Kilian Salerno, Lee S. Schwartzberg, Amy M. Sitapati, Karen L. Smith, Mary Lou Smith, Hatem Soliman, George Somlo, Melinda L. Telli, John H. Ward, Rashmi Kumar, Dorothy A. Shead - Journal of the National Comprehensive Cancer Network 2018 被引用: 1,616

  15. Early Local Therapy for the Primary Site in De Novo Stage IV Breast Cancer: Results of a Randomized Clinical Trial (E2108)

    著者: Seema A. Khan, Fengmin Zhao, Lori J. Goldstein, David Cella, Mark Basik, Mehra Golshan, Thomas B. Julian, Barbara A. Pockaj, Christine A. Lee, Wajeeha Razaq, Joseph A. Sparano, Gildy V. Babiera, Irene A. Dy, Sarika Jain, Paula Silverman, Carla S. Fisher, Amye J. Tevaarwerk, Lynne I. Wagner, George W. Sledge - Journal of Clinical Oncology 2022 被引用: 178

  16. Computational pathology improves risk stratification of a multi-gene assay for early stage ER+ breast cancer

    著者: Yuli Chen, Haojia Li, Andrew Janowczyk, Paula Toro, Germán Corredor, Jon Whitney, Cheng Lu, Can Koyuncu, Mojgan Mokhtari, Christina Buzzy, Shridar Ganesan, Michael D. Feldman, Pingfu Fu, Haley Corbin, Aparna Harbhajanka, Hannah Gilmore, Lori J. Goldstein, Nancy E. Davidson, Sangeeta Desai, Vani Parmar, Anant Madabhushi - npj Breast Cancer 2023 被引用: 28

  17. Dasatinib as a Single Agent in Triple-Negative Breast Cancer: Results of an Open-Label Phase 2 Study

    著者: Richard S. Finn, Carmelo Bengala, Nuhad K. Ibrahim, Henri Roché, Joseph A. Sparano, Lewis C. Strauss, Justin Fairchild, Oumar Sy, Lori J. Goldstein - Clinical Cancer Research 2011 被引用: 216

  18. Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy

    著者: Amyé Tevaarwerk, Robert J. Gray, Bryan P. Schneider, Mary Lou Smith, Lynne I. Wagner, John H. Fetting, Nancy E. Davidson, Lori J. Goldstein, Kathy D. Miller, Joseph A. Sparano - Cancer 2012 被引用: 193

  19. Collagen fiber orientation disorder from H&E images is prognostic for early stage breast cancer: clinical trial validation

    著者: Haojia Li, Kaustav Bera, Paula Toro, Pingfu Fu, Zelin Zhang, Cheng Lu, Michael D. Feldman, Shridar Ganesan, Lori J. Goldstein, Nancy E. Davidson, Akisha Glasgow, Aparna Harbhajanka, Hannah Gilmore, Anant Madabhushi - npj Breast Cancer 2021 被引用: 55

  20. Systemic Therapies Following Progression on First-line CDK4/6-inhibitor Treatment: Analysis of Real-world Data

    著者: James Martin, Elizabeth A. Handorf, Alberto J. Montero, Lori J. Goldstein - The Oncologist 2022 被引用: 56

  21. Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5–13/TESARO PR-30–50–10-C BRAVO Study

    著者: Nicholas C. Turner, Judith Balmañà, Coralie Poncet, Theodora Goulioti, Konstantinos Tryfonidis, Aafke H. Honkoop, Gabriele Zoppoli, Evangelia Razis, Óskar Þór Jóhannsson, Marco Colleoni, Andrew Tutt, William Audeh, Michail Ignatiadis, Audrey Mailliez, Olivier Trédan, Antonino Musolino, Peter Vuylsteke, María José Juan-Fita, Iain R. Macpherson, Bella Kaufman, Luís Manso, Lori J. Goldstein, Susan Ellard, István Láng, Kai Yu Jen, Virginie Adam, Saskia Litière, John K. Erban, David Cameron - Clinical Cancer Research 2021 被引用: 52

  22. Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer

    著者: I. Craig Henderson, Donald A. Berry, George D. Demetri, Constance Cirrincione, Lori J. Goldstein, Silvana Martino, James N. Ingle, M. Robert Cooper, Daniel F. Hayes, Katherine H. R. Tkaczuk, Gini F. Fleming, James F. Holland, David B. Duggan, John T. Carpenter, Emil Frei, Richard L. Schilsky, William C. Wood, Hyman B. Muss, Larry Norton - Journal of Clinical Oncology 2003 被引用: 1,302

  23. Breast Cancer, Version 3.2018

    著者: Matthew P. Goetz, William J. Gradishar, Benjamin O. Anderson, Jame Abraham, Rebecca Aft, Kimberly H. Allison, Sarah L. Blair, Harold J. Burstein, Chau T. Dang, Anthony Elias, William B. Farrar, Sharon H. Giordano, Lori J. Goldstein, Steven J. Isakoff, Janice A. Lyons, P. Kelly Marcom, Ingrid A. Mayer, Meena S. Moran, Joanne Mortimer, Ruth M. O'Regan, Sameer A. Patel, Lori J. Pierce, Elizabeth Reed, Hope S. Rugo, Amy M. Sitapati, Karen L. Smith, Mary Lou Smith, Hatem Soliman, Melinda L. Telli, John H. Ward, Jessica Young, Dorothy A. Shead, Rashmi Kumar - Journal of the National Comprehensive Cancer Network 2019 被引用: 199

  24. Cancer‐related relationship communication in couples coping with early stage breast cancer

    著者: Sharon L. Manne, Jamie S. Ostroff, Tina R. Norton, Kevin R. Fox, Lori J. Goldstein, Generosa Grana - Psycho-Oncology 2005 被引用: 307